Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-FR | Version v4-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-05-30 | 2023-01-27 |
| Drug Identification Number | 00804312 | 00804312 |
| Brand name | VITAMIN K1 INJ 10MG/ML USP | VITAMIN K1 INJ 10MG/ML USP |
| Common or Proper name | VITAMIN K1 | VITAMIN K1 |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | VITAMIN K1 | VITAMIN K1 |
| Strength(s) | 10MG | 10MG |
| Dosage form(s) | EMULSION | EMULSION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1ML | 1ML |
| ATC code | B02BA | B02BA |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2023-01-30 | 2023-01-30 |
| Estimated end date | 2023-05-26 | 2023-03-24 |
| Actual end date | 2023-05-02 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Baxter item: 9110 Product is available on allocation based on 75% of historical volumes. | Baxter item: 9110 Product is available on allocation based on 75% of historical volumes. |
| Health Canada comments |